Bosera CSI STAR&CHINEXT 50 ETF

The global stigmasterol-rich plant sterols market is projected to reach USD 1,281.42 million by 2036, driven by rising cardiovascular health awareness and demand for functional foods. The market is transitioning towards standardized formulations and regulatory support, with significant growth in applications across food, nutraceuticals, and pharmaceuticals. Key growth regions include India, Germany, and China, with a forecast CAGR of 3.8% from 2026 to 2036. The market is bolstered by increasing consumer preference for plant-based wellness solutions and regulatory approvals for health claims.

MorningStar

Stigmasterol-Rich Plant Sterols Market to Reach USD 1,281.42 Million by 2036 as Cardiovascular Health Awareness and Functional Food Demand Expand Globally

Senate Minority Leader Chuck Schumer criticized Donald Trump's recent trip to China, labeling it a 'photo op' that failed to address key issues such as fentanyl, Taiwan, U.S. manufacturing, and AI. Schumer stated that Trump returned with 'nothing to show for it' and highlighted concerns over the lack of action on fentanyl flow, protections for U.S. manufacturers, and doubts regarding U.S. commitment to Taiwan.

benzinga_article

NVIDIA

Alibaba

BABA-W

TENCENT

Tencent

NVIDIA Corporation

BABA-WR

Alibaba HK SDR 5to1

TENCENT-R

Tencent HK SDR 10to1

Tencent Holdings Limited

Chuck Schumer Slams Trump China Trip As 'Photo Op' With Xi Jinping, Says Visit Delivers 'Nothing' On Fentanyl, Taiwan And AI

The bleeding disorder testing market is projected to grow from USD 109.2 billion in 2025 to USD 234.6 billion by 2036, with a CAGR of 7.2%. This growth is driven by rising demand for performance-grade diagnostic solutions, increased hospital procurement, and a focus on regulatory compliance. Key segments include reagents and consumables, with hemophilia A being the leading indication. Major growth regions include China, India, Germany, France, and the United States, as healthcare institutions prioritize reliable diagnostic systems.

Siemens Healthineers AG

Roche

Thermo Fisher Scentific

Abbott Laboratories

Horiba , Ltd.

Pfizer

Baxter

ROCHE HOLDINGS AG

FMI Reveals Bleeding Disorder Testing Market USD 117.1 Billion in 2026 to USD 234.6 Billion by 2036 Driven by Expanding Demand for Performance-Grade Diagnostic Solutions

Chinese rehabilitation robot manufacturers are expanding into international markets, leveraging technological advancements despite facing regulatory challenges. Experts highlight the rapid development of robot technology and the importance of partnerships for market entry. The global rehabilitation equipment market is projected to grow significantly, driven by an aging population and increasing health issues. Companies are adapting their strategies to meet varying market receptiveness, particularly in Europe and the U.S.

Yicai

Chinese Rehab Robot Makers Leverage Tech Advantages to Expand Overseas, Experts Say

159370

589850

588390

As of March 13, 2026, the STAR & CHINEXT 50 Index rose nearly 1% during trading, with constituent stocks such as LONGSYS and JSG also experiencing gains. Cambricon announced a net profit of 2.059 billion yuan for 2025 and will cancel its stock identifier U on March 16, becoming the first "graduated" company. Guotou Securities and Huayuan Securities are optimistic about the domestic computing power market, believing that the growth in AI model usage will continue to drive demand for computing power, with a positive outlook for the domestic computing power sector. Related products include Taikang CSI Scientific Innovation and Entrepreneurship 50 Index Fund, covering popular industries such as semiconductors and AI computing power

腾讯新闻 - 财经

ICBCCS SZSE ChiNext 50 ETF

Eastmoney Fund SSE Science and Technology Innovation Board 50 ETF

Guotai CSI Scientific Innovation and Entrepreneurship 50 ETF

Taikang CSI 500 ETF

Cambricon

LONGSYS

China Merchants CSI Scientific Innovation and Entrepreneurship 50 ETF

China Southern CSI Scientific Innovation and Entrepreneurship 50 ETF

Pengyang CSI Scientific Innovation and Entrepreneurship 50 ETF

ChinaAMC CSI Scientific Innovation and Entrepreneurship 50 ETF

Yinhua CSI Scientific Innovation and Entrepreneurship 50 ETF

The Taikang CSI Scientific Innovation and Entrepreneurship 50 Index, which includes leading stocks in the computing power concept both domestically and internationally, rose nearly 1% during trading, with institutions optimistic about the continued high prosperity of domestic computing power

Bosera CSI STAR&CHINEXT 50 ETF(588390.SH)

Stigmasterol-Rich Plant Sterols Market to Reach USD 1,281.42 Million by 2036 as Cardiovascular Health Awareness and Functional Food Demand Expand Globally

Chuck Schumer Slams Trump China Trip As 'Photo Op' With Xi Jinping, Says Visit Delivers 'Nothing' On Fentanyl, Taiwan And AI

FMI Reveals Bleeding Disorder Testing Market USD 117.1 Billion in 2026 to USD 234.6 Billion by 2036 Driven by Expanding Demand for Performance-Grade Diagnostic Solutions

Chinese Rehab Robot Makers Leverage Tech Advantages to Expand Overseas, Experts Say

The Taikang CSI Scientific Innovation and Entrepreneurship 50 Index, which includes leading stocks in the computing power concept both domestically and internationally, rose nearly 1% during trading, with institutions optimistic about the continued high prosperity of domestic computing power